Castle Biosciences, Inc. · NASDAQ:CSTL

Portolan Capital Management, LLC reported a 5.65% stake in Castle Biosciences, Inc. (Schedule 13G)

Event Apr 7, 2025 · Filed Apr 14, 2025

Portolan Capital Management, LLC reported a 5.65% stake in Castle Biosciences, Inc., 1,611,099 shares, as a passive investor on Apr 7, 2025. Filed Apr 14, 2025 (Schedule 13G).

Stake
5.65%
Shares
1,611,099
Intent
Passive
What changed
Crossed above 5%
Filed together
2 holders

The filing in full

HolderStakeShares
Portolan Capital Management, LLC5.65%1,611,099
George McCabe5.65%1,611,099

Source

View original at SEC

Related